Breaking News Instant updates and real-time market news.

BAC

Bank of America

$22.55

-0.13 (-0.57%)

, AAPL

Apple

$118.99

1.08 (0.92%)

08:56
01/10/17
01/10
08:56
01/10/17
08:56

Notable open interest changes for January 10th

Monday's total option volume of 12.4 million contracts resulted in net open interest growth of 2.37 million calls and 2.60 million puts. Bank of America (BAC), Apple (AAPL), Facebook (FB) and Herbalife (HLF) saw the greatest growth. Top five new positions opened include 66k Bank of America (BAC) 1/13 weekly 24.5 calls, 20k VimpelCom (VIP) Mar-17 4 puts, 16k Disney (DIS) Jun-17 120 calls, 14k Ford (F) Jan-17 11 puts and 13k ARIAD (ARIA) May-17 24 calls.

BAC

Bank of America

$22.55

-0.13 (-0.57%)

AAPL

Apple

$118.99

1.08 (0.92%)

FB

Facebook

$124.90

1.49 (1.21%)

HLF

Herbalife

$49.53

-0.78 (-1.55%)

  • 11

    Jan

  • 12

    Jan

  • 13

    Jan

  • 01

    Feb

  • 28

    Feb

BAC Bank of America
$22.55

-0.13 (-0.57%)

01/10/17
SBSH
01/10/17
DOWNGRADE
Target $225
SBSH
Sell
Goldman Sachs downgraded to Sell from Neutral at Citi
Citi analyst Keith Horowitz downgraded Goldman Sachs (GS) to Sell with a $225 price target, representing 6% downside from current levels. While higher interest rates benefit fixed income trading, the path is "relatively uncertain and the bar is relatively high" for Goldman, Horowitz tells investors in a research note. The analyst believes U.S. bank stocks do not offer compelling risk/reward profiles following the recent rally. Horowitz this morning also downgraded Comerica (CMA) to Sell while keeping Buy ratings on Wells Fargo (WFC) and Bank of America (BAC).
01/09/17
WELS
01/09/17
NO CHANGE
WELS
Bank of America added to Priority Stock List at Wells Fargo
Wells Fargo added Bank of America to its Priority Stock List and identifies it as its top pick among large cap banks. The firm has "growing confidence" that the bank can benefit from multiple catalysts, including higher rates, prudent balance sheet growth, capital market improvement, and cost reductions.
12/21/16
12/21/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sunoco (SUN) upgraded to Outperform from Neutral at Credit Suisse with analyst John Edwards saying valuation is "underappreciated" and said a dividend cut is unlikely given options available for Sunoco and Energy Transfer Equity (ETE) to execute before reducing payouts. 2. BP (BP) and Statoil (STO) were upgraded to Buy from Neutral at UBS. 3. Citi (C) and Bank of America (BAC) were upgraded to Overweight from Neutral at Atlantic Equities while Morgan Stanley (MS) was upgraded to Neutral from Underweight. 4. Air Products (APD) upgraded to Buy from Neutral at Monness Crespi with the firm saying it thinks that Air Products will benefit from consolidation in the industry. It says that Air Products' balance sheet will enable it to "easily bid on and win new projects" and exploit divestitures in the sector. 5. Monster Beverage (MNST) upgraded to Buy from Hold at Jefferies with analyst Kevin Grundy calling the stock his top large cap growth pick in Consumer Products. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/21/16
ATLE
12/21/16
UPGRADE
Target $25
ATLE
Overweight
Bank of America upgraded due rising rates, lower taxes at Atlantic Equities
As previously reported, Atlantic Equities upgraded Bank of America to Overweight from Neutral with a $25 price target. Analyst Christopher Wheeler said Bank of America will be a major beneficiary of rising rates, strong capital markets, and potentially lower tax rates.
AAPL Apple
$118.99

1.08 (0.92%)

01/05/17
LBOW
01/05/17
NO CHANGE
LBOW
Apple 'near trough' valuation creates buying opportunity, says Longbow
After conducting checks, Longbow analyst Shawn Harrison says he expects "a good, not great iPhone 7 cycle." However, he says that the company's "near trough relative valuation represents a buying opportunity into a potentially much more robust next-gen iPhone cycle." Harrison keeps a $140 price target and a Buy rating on the stock.
01/09/17
DRXL
01/09/17
NO CHANGE
DRXL
Apple remains underappreciated, says Drexel Hamilton
Drexel Hamilton analyst Brian White said all the companies in his Apple Monitor have reported December sales that came in better than historical seasonality. Final December sales for the Apple Monitor fell by 2%, but were better than the average decrease of 11% over the past eleven years, and compare favorably to the five year average of down 6%. White believes Apple is one of the most underappreciated stocks in the world. Near-term, the analyst expects Tim Cook to make Apple grow again in Q1 on the back of the iPhone 7 and a happy holiday season, while he looks forward to the launch of the iPhone 8 in September 2017 and more color on future innovations. Additionally, White said potentially favorable tax repatriation policies could act as a positive catalyst for Apple shares. The analyst rates Apple a Buy with a $185 price target on shares.
01/04/17
01/04/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Guggenheim analyst Robert Cihra initiated Apple (AAPL) with a Buy rating and $140 price target, stating that while iPhones have slowed to now being cyclical he thinks the company can stay a step ahead of commoditization by maintaining its lead in software with iOS and processing with the Ax chip. 2. JPMorgan analyst Cory Kasimov started Global Blood Therapeutics (GBT) with an Overweight rating and $25 price target. If successful, the company's GBT440 would be the first new sickle cell disease therapy approved in two decades, Kasimov tells investors. 3. Needham analyst Laura Martin initiated Priceline (PCLN) with a Buy and a $1,800 price target due to its market lading position, history of execution, and OTA ecosystem competitive advantages. 4. Canaccord analyst Richard Close initiated Teladoc (TDOC) with a Buy rating and $24 price target. Close said Teladoc is the first mover, industry leader and the only publicly traded telemedicine company. 5. Guggenheim analyst Robert Cihra initiated Tesla (TSLA) with a Buy rating and $280 price target, as he acknowledges it faces a number of risks but also has "nearly open-ended growth disrupting the trillion-dollar auto market." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/09/17
MSCO
01/09/17
NO CHANGE
Target $148
MSCO
Overweight
Apple called a top U.S. IT Hardware pick for 2017 at Morgan Stanley
Morgan Stanley analyst Katy Huberty named Apple as a top pick in U.S. IT Hardware in 2017, saying that the market is "focusing too much on near-term supply chain noise" and not enough on the upcoming iPhone supercycle along with the potential positives of cash repatriation and U.S. tax reform. Of these, Huberty believes the iPhone supercycle is most debated by investors who see China as a risk, but her view is that consumer loyalty to Apple remains high in China. Huberty has an Overweight rating and $148 price target on Apple shares.
FB Facebook
$124.90

1.49 (1.21%)

01/10/17
JPMS
01/10/17
NO CHANGE
Target $165
JPMS
Overweight
JPMorgan reiterates Facebook as top large-cap Internet pick
JPMorgan analyst Doug Anmuth reiterates Facebook (FB) as hit top 2017 large-cap pick in the Internet space with an Overweight rating and $165 price target. Despite rallying 9% year-to-date, and trading only 6% below its all-time high reached on October 24, overall enthusiasm toward Facebook shares "remains somewhat muted," Anmuth tells investors in a research note. Concerns around revenue deceleration, slowing ad load growth, fake news and ad metrics have contributed to the "recent wall of worry," the analyst contends. Anmuth views the fears as largely overdone and thinks they create a good buying opportunity. The analyst also likes Netflix (NFLX) and Alphabet (GOOG) among large-caps and Yelp (YELP) and Match Group (MTCH) among small- and mid-caps.
01/10/17
COWN
01/10/17
NO CHANGE
COWN
Cowen raises media stock targets as survey shows digital acceleration continues
Cowen analysts John Blackledge and Tom Champion said the firm's proprietary Ad Survey shows digital continues to show acceleration, leading them to raise their price targets on some media stocks. Blackledge raised his digital ad forecast, sees mobile advertising at a tipping point, and sees video as the biggest share gainer within digital, at the expense of display. Blackledge raised his price target on Facebook (FB) to $156 from $150, and his Alphabet (GOOG) target to $1,050 from $1,000. Champion raised his price target on Criteo (CRTO) shares to $55 from $53.
01/05/17
PIPR
01/05/17
NO CHANGE
Target $150
PIPR
Overweight
Piper cuts Facebook target to $150 on peer multiples
Piper Jaffray analyst Samuel Kemp lowered his price target for Facebook shares to $150 from $185 to "better reflect the company's peer multiples." The stock closed yesterday up $1.83 to $118.69. A multiple of 13.5 times 2018 EBITDA expectations seems appropriate, Kemp tells investors in a research note. After initiating a long-term revenue outlook to reflect the individual contributions from Instagram and WhatsApp/ Messenger, however, the analyst is "more constructive" on Facebook's long-term fundamentals and continues to view the stock as undervalued. Putting together core Facebook, Instagram and WhatsApp/Messenger, Kemp arrives at a business that is roughly inline with Street estimates over the near term and triple revenue overall over the next decade, excluding the potential in Facebook's Oculus business. He keeps an Overweight rating on the shares.
01/09/17
OPCO
01/09/17
NO CHANGE
Target $144
OPCO
Outperform
Facebook pullback creates entry point, says Oppenheimer
Oppenheimer analyst Jason Helfstein says the recent pullback in Facebook's shares creates entry point, and notes it is his top large-cap pick for 2017. The analyst points out that shopping ads gained "significant" traction during the holidays, Facebook usage surged ahead of U.S. presidential election, and Instagram momentum is accelerating, driven by product innovation. He reiterates an Outperform rating and $144 price target on the shares.
HLF Herbalife
$49.53

-0.78 (-1.55%)

TODAY'S FREE FLY STORIES

21:00
05/26/17
05/26
21:00
05/26/17
21:00
General news
Breaking General news story  »

San Francisco Federal…

20:00
05/26/17
05/26
20:00
05/26/17
20:00
General news
Breaking General news story  »

San Francisco Federal…

JUNO

Juno Therapeutics

$23.30

-2.22 (-8.70%)

18:11
05/26/17
05/26
18:11
05/26/17
18:11
Hot Stocks
Juno Therapeutics director acquires 20,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

UNH

UnitedHealth

$177.50

-0.55 (-0.31%)

18:06
05/26/17
05/26
18:06
05/26/17
18:06
Hot Stocks
UnitedHealth's OptumHealth awarded $200.5M government contract »

UnitedHealth's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

VEC

Vectrus

$29.62

0.02 (0.07%)

17:56
05/26/17
05/26
17:56
05/26/17
17:56
Hot Stocks
Vectrus Systems awarded $212.03M modification to government contract »

Vectrus Systems was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMY

Imprimis

$3.34

-0.06 (-1.76%)

17:52
05/26/17
05/26
17:52
05/26/17
17:52
Syndicate
Breaking Syndicate news story on Imprimis »

Imprimis files $75M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRCP

IRSA Propiedades Comerciales

$43.58

-0.33 (-0.75%)

17:51
05/26/17
05/26
17:51
05/26/17
17:51
Syndicate
Breaking Syndicate news story on IRSA Propiedades Comerciales »

IRSA Propiedades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSKE

Daseke

$9.79

-0.11 (-1.11%)

17:44
05/26/17
05/26
17:44
05/26/17
17:44
Syndicate
Breaking Syndicate news story on Daseke »

Daseke files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECYT

Endocyte

$2.47

0.02 (0.82%)

, RNN

Rexahn

$4.04

0.09 (2.28%)

17:35
05/26/17
05/26
17:35
05/26/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Endocyte (ECYT),…

ECYT

Endocyte

$2.47

0.02 (0.82%)

RNN

Rexahn

$4.04

0.09 (2.28%)

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

ECYT

Endocyte

$2.47

0.02 (0.82%)

17:33
05/26/17
05/26
17:33
05/26/17
17:33
Hot Stocks
Endocyte to announce updated data on EC1456, EC1169 at ASCO »

Endocyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

PEP

PepsiCo

$117.91

0.38 (0.32%)

17:30
05/26/17
05/26
17:30
05/26/17
17:30
Periodicals
PepsiCo in talks to acquire Vita Coco owner All Market, Reuters reports »

PepsiCo is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCOV

Brightcove

$6.25

0.25 (4.17%)

17:25
05/26/17
05/26
17:25
05/26/17
17:25
Hot Stocks
Breaking Hot Stocks news story on Brightcove »

ESW Capital reports 8.08%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

SHIP

Seanergy Marine

$0.69

0.001244 (0.18%)

17:19
05/26/17
05/26
17:19
05/26/17
17:19
Hot Stocks
Seanergy Marine receives Nasdaq notice »

Seanergy Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$10.93

0.07 (0.64%)

, DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

17:10
05/26/17
05/26
17:10
05/26/17
17:10
General news
S&P advances to end week at record as Fed signals no rush to normalize policy »

The S&P 500 (SPX)…

F

Ford

$10.93

0.07 (0.64%)

DB

Deutsche Bank

$18.46

-0.39 (-2.07%)

BBY

Best Buy

$58.97

-2.28 (-3.72%)

HPQ

HP Inc.

$18.47

0.1 (0.54%)

BX

Blackstone

$32.58

0.11 (0.34%)

NOK

Nokia

$6.38

-0.02 (-0.31%)

AAPL

Apple

$153.61

-0.26 (-0.17%)

GM

General Motors

$33.07

0.47 (1.44%)

HUN

Huntsman

$24.75

-0.11 (-0.44%)

BF.A

Brown-Forman, also tag with BFA, BFB

$52.49

-0.21 (-0.40%)

BF.B

Brown-Forman, also tag with BFA, BFB

$51.73

0.13 (0.25%)

STZ

Constellation Brands

$180.93

0.79 (0.44%)

LOW

Lowe's

$80.91

-0.42 (-0.52%)

TIF

Tiffany

$86.18

0.36 (0.42%)

SHLD

Sears

$7.78

-0.7 (-8.25%)

SIG

Signet Jewelers

$49.31

-0.99 (-1.97%)

COST

Costco

$177.86

3.13 (1.79%)

ANF

Abercrombie & Fitch

$13.22

-0.83 (-5.91%)

AEO

American Eagle

$11.50

0.08 (0.70%)

EXPR

Express

$7.85

0.03 (0.38%)

TTWO

Take-Two

$77.07

-1.46 (-1.86%)

AZO

AutoZone

$615.62

8.28 (1.36%)

DSW

DSW

$16.73

-0.06 (-0.36%)

INTU

Intuit

$138.56

0.2 (0.14%)

PBYI

Puma Biotechnology

$79.75

1.7 (2.18%)

CHS

Chico's

$9.37

-0.39 (-4.00%)

SPLS

Staples

$8.98

-0.08 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 01

    Jun

  • 01

    Jun

  • 01

    Jun

  • 02

    Jun

  • 06

    Jun

  • 06

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 12

    Jun

  • 13

    Jun

  • 20

    Jun

  • 28

    Jun

  • 21

    Jul

BGNE

BeiGene

$37.42

-0.04 (-0.11%)

17:07
05/26/17
05/26
17:07
05/26/17
17:07
Syndicate
Breaking Syndicate news story on BeiGene »

BeiGene files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 06

    Jun

CGI

Celadon Group

17:06
05/26/17
05/26
17:06
05/26/17
17:06
Hot Stocks
Breaking Hot Stocks news story on Celadon Group »

Litespeed Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRD

Crawford & Company Inc.

, CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

17:05
05/26/17
05/26
17:05
05/26/17
17:05
Hot Stocks
Crawford & Company COO Robinson to leave company »

Crawford & Company…

CRD

Crawford & Company Inc.

CRDA

Crawford & Co.

$7.65

0.01 (0.13%)

CRDB

Crawford & Company

$9.08

-0.02 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$18.08

-0.13 (-0.71%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Hot Stocks
Breaking Hot Stocks news story on SeaWorld »

Hill Path Capital raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMRC

Digimarc

$36.10

2.45 (7.28%)

17:03
05/26/17
05/26
17:03
05/26/17
17:03
Syndicate
Breaking Syndicate news story on Digimarc »

Digimarc files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 06

    Sep

IPCI

Intellipharmaceutics

$1.94

-0.01 (-0.51%)

17:01
05/26/17
05/26
17:01
05/26/17
17:01
Syndicate
Breaking Syndicate news story on Intellipharmaceutics »

Intellipharmaceutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GWR

Genesee & Wyoming

$66.47

0.91 (1.39%)

16:57
05/26/17
05/26
16:57
05/26/17
16:57
Hot Stocks
Genesee & Wyoming CEO Hellmann named chairman of the board »

Genesee & Wyoming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZG

Paramount Gold Nevada

$1.61

0.02 (1.26%)

16:54
05/26/17
05/26
16:54
05/26/17
16:54
Syndicate
Breaking Syndicate news story on Paramount Gold Nevada »

Paramount Gold Nevada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$7.25

-0.55 (-7.05%)

16:53
05/26/17
05/26
16:53
05/26/17
16:53
Syndicate
Breaking Syndicate news story on Sangamo »

Sangamo files $200M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

TGTX

TG Therapeutics

$12.05

0.15 (1.26%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on TG Therapeutics »

TG Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 22

    Jun

AVXL

Anavex

$5.88

-0.06 (-1.01%)

16:49
05/26/17
05/26
16:49
05/26/17
16:49
Syndicate
Breaking Syndicate news story on Anavex »

Anavex files to sell 5M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.